Device Trial Radar · NCT03561857
Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology Surgery
Last checked: Nov 20, 2026Latest source record: Jan 28, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Jan 16, 2019
Primary completion
Jun 2020
Study completion Jun 2020
Sponsor
- Lead sponsor
- Mauna Kea TechnologiesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 19, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This multicenter study aimed at assessing the feasibility of Probe-based Confocal Laser Endomicroscopy (pCLE) during Robotic-Assisted Radical Prostatectomy or Laparoscopic Radical Prostatectomy for intra-operative characterisation of surgical margins.
Conditions
- Prostate Cancer
Interventions
Confocal Laser EndomicroscopyDevice
The study is divided in 2 parts. 1. Ex vivo study * Prostate specimens will be stained using Fluorescein * Images/sequences of normal and abnormal prostatic tissues, and peri-prostatic tissues will be acquired. 2. In vivo study * Intravenous injection of contrast agent * pCLE imaging every 5mm of the NVB dissection zone.
Primary outcomes
What the sponsor says the trial is designed to measure.
- pCLE criteriaTime frame: 1 year
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Groupe Hospitalier Diaconesses Croix Saint-Simon
Paris, France · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.